Vontobel Holding Ltd. Sells 3,000 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)

Vontobel Holding Ltd. cut its holdings in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 44.1% during the third quarter, Holdings Channel.com reports. The fund owned 3,800 shares of the company’s stock after selling 3,000 shares during the period. Vontobel Holding Ltd.’s holdings in VanEck Pharmaceutical ETF were worth $361,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of PPH. Optimum Investment Advisors bought a new stake in VanEck Pharmaceutical ETF during the second quarter valued at about $27,000. GPS Wealth Strategies Group LLC bought a new stake in VanEck Pharmaceutical ETF during the second quarter valued at about $42,000. CWM LLC bought a new stake in VanEck Pharmaceutical ETF during the second quarter valued at about $55,000. International Assets Investment Management LLC bought a new stake in VanEck Pharmaceutical ETF during the second quarter valued at about $86,000. Finally, Comerica Bank increased its holdings in shares of VanEck Pharmaceutical ETF by 39.4% in the first quarter. Comerica Bank now owns 1,337 shares of the company’s stock worth $121,000 after purchasing an additional 378 shares during the last quarter.

VanEck Pharmaceutical ETF Trading Down 0.0 %

Shares of PPH stock opened at $93.59 on Wednesday. VanEck Pharmaceutical ETF has a 12-month low of $74.05 and a 12-month high of $99.51. The stock’s 50-day moving average price is $96.19 and its 200-day moving average price is $92.51. The stock has a market capitalization of $719.71 million, a price-to-earnings ratio of 21.04 and a beta of 0.72.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.